Beta-catenin mutations are not observed in chronic myeloid leukemia

Tumori

Volumn 95, Issue 6, 2009, Pages 836-839

  Sercan, Zeynep ^a   Pehlivan, Melek ^a   Gokturk, Dilek ^a   Sercan, Hakki Ogun ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

BCR ABL; Beta catenin; Chronic myeloid leukemia; Wnt signaling

Indexed keywords

BETA CATENIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BONE MARROW BIOPSY; CANCER GENETICS; CANCER PATIENT; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE MUTATION; HUMAN; HUMAN TISSUE;

EID: 76349105946     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160909500633     Document Type: Article

References (24)

1. Hehlman R, Hochhaus A, Baccarani M on behalf of the European LeukemiaNet: Chronic myeloid leukemia. Lancet, 370: 342-350, 2007.
2. Melo JV, Barnes DJ: Chronic myeloid leukemia as a model of disease evolution in human cancer. Nat Rev Cancer, 7: 441-453, 2007.
3. Deininger MWN: Optimizing therapy of chronic myeloid leukemia. Exp Hematol, 35: 144-154, 2007.
4. Goldman JM: Chronic myeloid leukemia-still a few questions. Exp Hematol, 32: 2-10, 2006.
5. Clarkson BD, Strife A, Wisneiwski D, Lambek C, Carpino N: New understanding of the pathogenesis of CML: a prototype of early neoplasia. Leukemia, 11: 1404-1428, 1997.
6. Staal FJ, Clevers HC: WNT signaling and haematopoiesis: a WNT-WNT situation. Nat Rev Immunol, 5: 21-30, 2005.
7. Reya T, Duncan A, Ailles L, Domen J, Scherer DC, Willert K, Hintz L, Nusse R, Weissman IL: A role for Wnt signaling in self-renewal of haematopoietic stem cells. Nature, 423: 409-414, 2003.
8. Rattis FM, Voermans C, Reya T: Wnt signaling in the stem cell niche. Curr Opin Hematol, 11: 88-94, 2004.
9. Logan CY, Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol, 20: 781-810, 2004.
10. Widelitz R: Wnt signaling through canonical and non-canonical pathways: recent progress. Growth Factors, 23: 111-116, 2005.
11. Polakis P: Wnt signaling and cancer. Genes Dev, 14: 1837-1851, 2000.
12. Khan NI, Bendall LI: Role of WNT signaling in normal and malignant hematopoiesis. Histol Histopathol, 21: 761-774, 2006.
13. Morin PJ, Sparks AB, Korinek V Barker N, Clevers H, Vogelstein B, Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science, 275: 1787-1790, 1997.
14. Rubenfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P: Stabilization of β-catenin by genetic defects in melanoma cell lines. Science, 275: 1790-1792, 1997.
15. Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, Mann M, Ben-Neriah Y, Alkalay I: Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev, 16: 1066-1076, 2002.
16. Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, Gotlib J, Li K, Manz MG, Keating A, Sawyers CL, Weissman IL: Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med, 351: 657-667, 2004.
17. Radich JP, Dai H, Mao M, Oehler V, Schelter J, Druker B, Sawyers C, Shah N, Stock W, Willman CL, Friend S, Linsley PS: Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci, 103: 2794-2799, 2006.
18. Ress A, Moelling K: Bcr is a negative regulator of the Wnt signaling pathway. EMBO Rep, 6: 1095-1100, 2005.
19. Coluccia AM, Vacca A, Dunarch M, Mologni L, Redaelli S, Bustos VH, Benati D, Pinna LA, Gambacorti-Passerini C: Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation. EMBO J, 26: 1456-1466, 2007.
20. Zhao C, Blum J, Chen A, Kwon HY, Jung SH, Cook JM, Lagoo A, Reya T: Loss of β-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell, 12: 528-541, 2007.
21. Sengupta A, Banerjee D, Chandra S, Banerji SK, Ghosh R, Roy R, Banerjee S: Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia, 21: 949-955, 2007.
22. rd ed, Oxford University Press Inc, New York, 2001.
23. Moore MAS: Converging pathways in leukomogenesis and stem cell renewal. Exp Hematol, 33: 719-737, 2005.
24. Kavalerchik E, Goff D, Jamieson CHM: Chronic myeloid leukemia stem cells. J Clin Oncol, 26: 2911-2915, 2008.